Development of Monoclonal Antibodies for Diagnosis of Plasmodium vivax
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Plasmodium lactate dehydrogenase (pLDH) is a strong target antigen for the determination of infection with Plasmodium species specifically. However, a more effective antibody is needed because of the low sensitivity of the current antibody in many immunological diagnostic assays. In this study, recombinant Plasmodium vivax LDH (PvLDH) was experimentally constructed and expressed as a native antigen to develop an effective P. vivax-specific monoclonal antibody (mAb). Two mAbs (2CF5 and 1G10) were tested using ELISA and immunofluorescence assays (IFA), as both demonstrated reactivity against pLDH antigen. Of the 2 antibodies, 2CF5 was not able to detect P. falciparum, suggesting that it might possess P. vivax-specificity. The detection limit for a pair of 2 mAbs-linked sandwich ELISA was 31.3 ng/ml of the recombinant antigen. The P. vivax-specific performance of mAbs-linked ELISA was confirmed by in vitro-cultured P. falciparum and P. vivax-infected patient blood samples. In conclusion, the 2 new antibodies possessed the potential to detect P. vivax and will be useful in immunoassay.
Abstract
Plasmodium lactate dehydrogenase (pLDH) is a strong target antigen for the determination of infection with Plasmodium species specifically. However, a more effective antibody is needed because of the low sensitivity of the current antibody in many immunological diagnostic assays. In this study, recombinant Plasmodium vivax LDH (PvLDH) was experimentally constructed and expressed as a native antigen to develop an effective P. vivax-specific monoclonal antibody (mAb). Two mAbs (2CF5 and 1G10) were tested using ELISA and immunofluorescence assays (IFA), as both demonstrated reactivity against pLDH antigen. Of the 2 antibodies, 2CF5 was not able to detect P. falciparum, suggesting that it might possess P. vivax-specificity. The detection limit for a pair of 2 mAbs-linked sandwich ELISA was 31.3 ng/ml of the recombinant antigen. The P. vivax-specific performance of mAbs-linked ELISA was confirmed by in vitro-cultured P. falciparum and P. vivax-infected patient blood samples. In conclusion, the 2 new antibodies possessed the potential to detect P. vivax and will be useful in immunoassay.
참고문헌 (20)
- "Malaria"[URL]
- Bartoloni A, "Clinical aspects of uncomplicated and severe malaria", Mediterr J Hematol Infect Dis, 4, pp.e2012026~ (2012)
- Baird JK, "Diagnosis and treatment of Plasmodium vivax malaria", Am J Trop Med Hyg, 95, pp.35~51 (2016)
- Verma P, "Detection of histidine rich protein and lactate dehydrogenase of Plasmodium falciparum in malaria patients by sandwich ELISA using in-house reagents", Indian J Med Res, 138, pp.977~987 (2013)
- Dzakah EE, "Plasmodium vivax aldolase-specific monoclonal antibodies and its application in clinical diagnosis of malaria infections in China", Malar J, 12, pp.199~ (2013)
- Meier B, "Stage-specific expression of aldolase isoenzymes in the rodent malaria parasite Plasmodium berghei", Mol Biochem Parasitol, 52, pp.15~27 (1992)
- Harani MS, "Role of ICT malaria immunochromatographic test for rapid diagnosis of malaria", J Pak Med Assoc, 56, pp.167~171 (2006)
- Dzakah EE, "Comparative performance of aldolase and lactate dehydrogenase rapid diagnostic tests in Plasmodium vivax detection", Malar J, 13, pp.272~ (2014)
- Köhler G, "Continuous cultures of fused cells secreting antibody of predefined specificity", Nature, 256, pp.495~497 (1975)
- Galfrè G, "Preparation of monoclonal antibodies : strategies and procedures", Methods Enzymol, 73, pp.3~46 (1981)
- Armbruster DA, "Limit of blank, limit of detection and limit of quantitation", Clin Biochem Rev, 29(suppl), pp.49~52 (2008)
- Mendis K, "The neglected burden of Plasmodium vivax malaria", Am J Trop Med Hyg, 64, pp.97~106 (2001)
- Beeson JG, "Plasmodium vivax malaria: challenges in diagnosis, treatment and elimination", Pediatr Infect Dis J, 34, pp.529~531 (2015)
- Moody A, "Rapid diagnostic tests for malaria parasites", Clin Microbiol Rev, 15, pp.66~78 (2002)
- Heutmekers M, "Evaluation of the rapid diagnostic test CareStart pLDH Malaria(Pf-pLDH", pan-pLDH)for the diagnosis of malaria in a reference setting, 2012, pp.11, 204~
- "Malaria Rapid Diagnostic Test Performance:result of WHO product testing of malaria RDTs Round 3 (2010-2011)" (2011)[URL]
- Abba K, "Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries", Cochrane Database Syst Rev, pp.CD008122~ (2011)
- Ouattara A, "Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali", Malar J, 10, pp.345~ (2011)
- Bashir IM, "Comparison of PfHRP-2", pLDH ELISA, qPCR and microscopy for the detection of Plasmodium events and prediction of sick visits during a malaria vaccine study, 2013, pp.8, e56828~
- Kim JH, "Production of monoclonal antibodies for Plasmodium vivax lactate dehydrogenase and patient sera screening using sandwich ELISA", Parasitol Res, 111, pp.1645~1650 (2012)